A practical reference on peptide fragment: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-10-23 and is reviewed periodically as new material appears.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
| Property | Value | Notes |
|---|---|---|
| Analytical method | LC-MS/MS | Preferred confirmatory technique |
| Appearance | White to off-white powder | Lyophilised form |
| Solubility | Freely soluble in water | Also described in saline |
| Storage temperature | Below -20 °C for powder | Short-term refrigeration for solutions |
| Regulatory status | Prohibited in sport | Listed under peptide hormones |
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
=== Drug dependence === Drug dependence is another problem associated with ADH, which researchers think might be linked to alcoholism. One particular study suggests that drug dependence has seven ADH genes associated with it, however, more research is necessary. Alcohol dependence and other drug dependence may share some risk factors, but because alcohol dependence is often comorbid with other drug dependences, the association of ADH with the other drug dependencies may not be causal.
Another potential strategy that can facilitate rapid assembly and enhance stability of DNA bricks is the use of the kinetically interlocking multiple-unit (KIMU) strategy. This strategy was used to determine if multiple unit-DNA (MUD) strands could improve structural stability and accelerate the annealing process for medium to long length DNA strands compared to the traditional short-strand DNA brick assemblies. The KIMU theory suggests that increasing the number of noncovalent units can improve the stability of DNA assembly, create DNA bricks with lengths of ~50 nucleotides, and increase collision between DNA bricks. The MUD assemblies increased the local concentration of nucleotide units and enabled well-assembled DNA structures to recover more readily through kinetic interlocking after dissolution. This interlocking, facilitated by the interaction among multiple units, enhanced the stability of the previous assembly composed entirely of short DNA strands, offering an alternative strategy to fabricate longer but stable DNA structures.
Johnson then called a snap election in 2019, where he campaigned on a platform to "Get Brexit Done." The Conservatives won the largest majority in the House of Commons since the 1987 election, leading to the passing of a Brexit deal early in the next decade.
However, the biological effects of radiation due to radioactive substances were less easy to gauge. This gave the opportunity for many physicians and corporations to market radioactive substances as patent medicines. Examples were radium enema treatments, and radium-containing waters to be drunk as tonics. Marie Curie protested against this sort of treatment, warning that "radium is dangerous in untrained hands". Curie later died from aplastic anaemia, likely caused by exposure to ionizing radiation. By the 1930s, after a number of cases of bone necrosis and death of radium treatment enthusiasts, radium-containing medicinal products had been largely removed from the market (radioactive quackery).
After the Qatari Ministry of Defence announced on 2 March that two Iranian drones attacked Qatari gas facilities, followed closely by an announcement from QatarEnergy that all gas production in the country had been halted, European natural gas prices nearly doubled. This raised concerns over energy security and fertiliser costs. EU natural gas prices decreased again to a less-high €48/MWh on Wednesday 4 March. The Iran conflict also bolstered the necessity for renewable energy, as solar and wind power can reduce vulnerability to external supply and decentralised power generation that offers greater autonomy from global energy markets. With fluctuating oil prices, renewable energy has become significantly more cost-competitive. April 2026 was the strongest month of electric vehicle sales on record in Europe. Shell plc's CEO warned that Europe could face shortages of fuel by April. British supermarket chain Asda warned that it was already facing shortages of fuel at their fuel stations. In addition to broader fuel supply disruptions, reports in April 2026 indicated significant impacts on global energy and aviation markets linked to tensions in the Strait of Hormuz during the Iran–United States conflict. Restricted maritime traffic was reported to have contributed to supply constraints in oil and jet fuel, affecting global energy flows and increasing market volatility. The disruption contributed to sharp increases in global energy prices.
Sources: en.wikipedia.org
Outside Romania, public audiences in Western Europe initially projected generally idealistic notions of revolution on the country; the legacies of the French Revolution were fresh on people's minds in 1989 during its two-hundredth anniversary. However, as violence continued into 1990 and reports reached the West of mass casualties, this projected narrative shifted into a less sympathetic one characterized by disappointment in and suspicion of the revolution's direction.
== Regulation == H2S decreases transcription of cystathionase at concentrations between 10 and 80 μM. However, transcription is increased by concentrations near 120 μM, and inhibited completely at concentrations in excess of 160 μM.
K, is a factor dependent on the preferred probability level. Usually, it is set at 2.77, which reflects a 95% prediction interval, in which case there is less than 5% probability that a test result would become higher or lower than the critical difference by test-retest variability in the absence of other factors. CVa is the analytical variation CVi is the intra-individual variability For example, if a patient has a hemoglobin level of 100 g/L, the analytical variation (CVa) is 1.8% and the intra-individual variability CVi is 2.2%, then the critical difference is 8.1 g/L. Thus, for changes of less than 8 g/L since a previous test, the possibility that the change is completely caused by test-retest variability may need to be considered in addition to considering effects of, for example, diseases or treatments.
Due to actinium's intense radioactivity, only a limited number of actinium compounds are known. These include: AcF3, AcCl3, AcBr3, AcOF, AcOCl, AcOBr, Ac2S3, Ac2O3, AcPO4 and Ac(NO3)3. They all contain actinium in the oxidation state +3. In particular, the lattice constants of the analogous lanthanum and actinium compounds differ by only a few percent.
== Comparison == The following table compares some common anti-diabetic agents, generalizing classes, although there may be substantial variation in individual drugs of each class. When the table makes a comparison such as "lower risk" or "more convenient" the comparison is with the other drugs on the table.
Sources: en.wikipedia.org
===== Euarchontoglires ===== Order Lagomorpha Family Leporidae Oryctolagus cuniculus, European rabbit (2010) Order Primates Family Callitrichidae Callithrix jacchus, Common marmoset (2010, whole genome 2014) Family Cercopithecidae Macaca mulatta, rhesus macaque (2007 & Chinese rhesus macaque Macaca mulatta lasiota in 2011) Macaca fascicularis, Cynomolgus or crab-eating macaque (2011) Papio anubis, olive baboon (2020) Papio cynocephalus, yellow baboon (2016) Rhinopithecus roxellana, golden snub-nosed monkey (2019) Family Galagidae Otolemur garnettii, small-eared galago, or bushbaby () Family Hominidae Subfamily Ponginae Pongo pygmaeus/Pongo abelii, orangutan (Borneo/Sumatra) (2011) Subfamily Homininae Gorilla gorilla, western gorilla (2012) Homo sapiens, modern human (draft 2001, whole genome 2022) † Homo neanderthalensis, Neanderthal (draft 2010) Pan troglodytes, chimpanzee (2005) Pan paniscus, bonobo (2012) Order Rodentia Family Caviidae Hydrochoerus hydrochaeris, capybara (2018) Family Cricetidae Microtus montanus, Montane vole (2021) Microtus richardsoni, North American Water Vole (2021) Peromyscus leucopus, white-footed mouse (2019) Family Heteromyidae Perognathus longimembris pacificus, Pacific Pocket Mouse Family Muridae Mastomys coucha, Southern multimammate mouse (2019) Mus musculus Strain: C57BL/6J, House mouse (2002) Rattus norvegicus, Brown rat (2004)
=== Arm === Types of upper extremity amputations include: partial hand amputation wrist disarticulation trans-radial amputation, commonly referred to as below-elbow or forearm amputation elbow disarticulation trans-humeral amputation, commonly referred to as above-elbow amputation shoulder disarticulation forequarter amputation A variant of the trans-radial amputation is the Krukenberg procedure in which the radius and ulna are used to create a stump capable of a pincer action.
Saddam's foreign minister Tariq Aziz later told PBS Frontline in 1996 that the Iraqi leadership was under "no illusion" about America's likely response to the Iraqi invasion: "She [Glaspie] didn't tell us anything strange. She didn't tell us in the sense that we concluded that the Americans will not retaliate. That was nonsense you see. It was nonsense to think that the Americans would not attack us." Then in a second 2000 interview with the same television program, Aziz said:There were no mixed signals. We should not forget that the whole period before August 2 witnessed a negative American policy towards Iraq. So it would be quite foolish to think that, if we go to Kuwait, then America would like that. Because the American tendency ... was to untie Iraq. So how could we imagine that such a step was going to be appreciated by the Americans? It looks foolish, you see, this is fiction. About the meeting with April Glaspie—it was a routine meeting...She didn't say anything extraordinary beyond what any professional diplomat would say without previous instructions from his government...what she said were routine, classical comments on what the president was asking her to convey to President Bush. He wanted her to carry a message to George Bush—not to receive a message through her from Washington.
==== Detection ==== Cabbage loopers possess olfactory receptor neurons on their antennae for detecting pheromones. The neurons are specifically located on two sensory structures called sensilla that differ in length and pore density. Male loopers have two types of neurons, and depending on which sensilla that are present, the neurons will detect female pheromones at varying sensitivities to each of the six pheromones. The neurons are most sensitive to the main component of the female pheromone blend, cis-7-dodecenyl acetate, and the male inhibitory signal, cis-7-dodecenol. The presence of cis-7-dodecenyl acetate is crucial for male response to female pheromones, as it is 80% of the entire blend. The base region of the antennae, where receptor neurons for this pheromone are located, has more sensory structures than the ends. The base region is also less likely to experience damage, showing the importance of detecting the pheromone. It is not clear why male neurons detect the inhibitory compound, as there is no evidence showing that females produce this compound. One possibility is that its presence in the female pheromone blend may be too small to be detected by scientific equipment. The inhibitory signal only elicits a response when delivered alongside female pheromones to avoid mixing signals from other species, suggesting that while it cannot be detected in the female pheromone blend, it has an important role in female detection. These neurons are also capable of recognizing and responding to cis-7-tetradecenyl acetate and cis-9-tetradecenyl acetate.
== 2009 settlement for off-label uses promotions == On September 2, 2009, the United States Department of Justice fined Pfizer $2.3 billion after one of its subsidiaries, Pharmacia & Upjohn Company, pleaded guilty to marketing four drugs, including Bextra, "with the intent to defraud or mislead." Pharmacia & Upjohn admitted to criminal conduct in the promotion of Bextra, and agreed to pay the largest criminal fine ever imposed in the United States for any matter, $1.195 billion. A former Pfizer district sales manager was indicted and sentenced to home confinement for destroying documents regarding the illegal promotion of Bextra. In addition, a regional manager pleaded guilty to distribution of a misbranded product, and was fined $75,000 and 24 months on probation. The remaining $1 billion of the fine were paid to resolve allegations under the civil False Claims Act case and is the largest civil fraud settlement against a pharmaceutical company. Six whistleblowers were awarded more than $102 million for their role in the investigation. Former Pfizer sales representative John Kopchinski acted as a qui tam relator and filed a complaint in 2004 outlining the illegal conduct in the marketing of Bextra. Kopchinski was awarded $51.5 million for his role in the case because the improper marketing of Bextra was the largest piece of the settlement at $1.8 billion.
Sources: en.wikipedia.org
The most common approach is liquid chromatography with tandem mass spectrometry after extraction from blood or urine. Immunoassays exist but are generally treated as screening tools because of cross-reactivity.
Dry lyophilised powder is normally kept frozen and protected from moisture and light. Dissolved material is handled cold and used promptly to limit degradation.
It is not licensed as a medicine in major markets and is distributed as a research chemical. Sports organisations prohibit its use, and some countries restrict import and supply.
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.